Patrick Y Wen

Also affiliated with Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Phase II trial of blood–brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma”.

Phase II trial of blood–brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae186

N/A

0.574DataRank · unranked

17 citations

Andrew Brenner, David Piccioni, Patrick Y Wen, Jan Drappatz, Maciej Mrugala +10 more

Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac041

N/A

0DataRank · unranked

10 citations

S. Keith Anderson, Erin Twohy, Nicholas Butowski, Adı́lia Hormigo, David Schiff +11 more

Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management

Neuro-Oncology(2023)10.1093/neuonc/noad154

N/A

0DataRank · unranked

99 citations

Steven Tobochnik, Sara K. Inati, Johan A F Koekkoek, Guy M. McKhann, James J. Riviello +7 more

Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group

Neuro-Oncology(2024)10.1093/neuonc/noae231

N/A

0DataRank · unranked

17 citations

Jacob S. Young, Gilbert C Youssef, Antonio Dono, Levin Häni, Tommaso Sciortino +25 more

A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group

The Lancet Oncology(2025)10.1016/s1470-2045(25)00534-0

N/A

0DataRank · unranked

17 citations

Jacob S. Young, Maarten M.J. Wijnenga, Tommaso Sciortino, Nico Teske, Alba Corell +44 more